Get startedLog in
    Picture of Ilshinbiobase Co logo

    068330 — Ilshinbiobase Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Ilshinbiobase Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsARSAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,9716,2453,8156,2323,812
    Depreciation
    Amortisation
    Non-Cash Items2,6922,9251,715526-673
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-2,744-3,001-3,345-1,294542
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities4,5036,7452,6465,9244,121
    Capital Expenditures-893-139-93.3-262—
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-271-3,971-7,886-5,552-5,260
    Acquisition of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Sale of Intangible Assets
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-1,164-4,110-7,980-5,815-5,260
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-300-309-309-2,648-292
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2,9612,323-5,659-2,562-1,420